# Hour 06: 06:00-06:59 - Morning Ramp Begins

Released on 1 May 2026 | CEO Kevin Kawchak | ChemicalQDevice

## Hour Summary

Morning ramp. STREAM C2D1 infusion completes for PAT-CONT-0013A. 4 new
arrivals across the network. Network utilization climbs to 1.6%.

## Cross-Site Status at 06:00 UTC

| Site | Patients | Active | Standby | Active | Signal |
|------|----------|--------|---------|--------|--------|
| SITE-A | 7 | 0 | 29 | 0 | UP |
| SITE-B | 6 | 0 | 29 | 0 | UP |
| SITE-C | 5 | 1 | 28 | 1 | UP |
| SITE-D | 4 | 0 | 29 | 0 | UP |

## New Arrivals

| Patient ID | Site | Time | Cancer | Robot |
|------------|------|------|--------|-------|
| PAT-CONT-0014A | SITE-A | 06:05 | Mediastinal tumor | Surgical (1) |
| PAT-CONT-0015A | SITE-B | 06:18 | Parotid tumor | Needle-Placement (4) |
| PAT-CONT-0016A | SITE-D | 06:32 | Pediatric ALL maintenance | Companion (5) |
| PAT-CONT-0017A | SITE-A | 06:50 | NSCLC | RT Motion-Tracking (7) |

## Minute Activity Log

```
06:00 Hour-boundary FDA recon: 2/2 endpoints accepted.
06:00-06:30 STREAM C2D1 infusion ongoing for PAT-CONT-0013A (SITE-C).
06:05 PAT-CONT-0014A check-in SITE-A. Pre-op for mediastinal mass excision.
06:06-06:14 SURG-01 (SITE-A) wakes; pre-anesthesia setup.
06:15-06:30 Robotic-assisted minimally invasive thoracic procedure.
06:18 PAT-CONT-0015A check-in SITE-B. CT-guided parotid biopsy.
06:19-06:25 NEEDLE-01 (SITE-B) wakes, CT registration.
06:26-06:42 Needle placement and biopsy.
06:30 STREAM infusion complete (60 min ARM-B 'placebo'); endpoint streamed
      STREAM-CONT-0013A-IND-C2D1, FDA ack 06:30+9s.
06:31 SURG procedure milestone reached at 06:30; resection ongoing.
06:32 PAT-CONT-0016A check-in SITE-D. Pediatric maintenance dose.
06:33-06:48 COMPN-05 engagement + oral 6-MP supervision.
06:43 NEEDLE-01 retracts. Patient to recovery (SITE-B).
06:44 BX endpoint streamed: TRAVERSE-CONT-0015A-BX01. FDA ack 06:44+12s.
06:45 SURG procedure complete. Mass excised (R0 margins, frozen section).
06:46 SURG endpoint streamed: TRAVERSE-CONT-0014A-SURG01. FDA ack 06:46+10s.
06:47-06:49 SURG-01 closing/cleanup; patient to recovery bay 1.
06:48 Pediatric maintenance complete; endpoint streamed
      TRAVERSE-PED-CONT-0016A-MAINT01. FDA ack 06:48+11s.
06:50 PAT-CONT-0017A check-in SITE-A. RT fraction 22 of 30.
06:51-06:52 RTPOS-01 + TRACK-01 wake.
06:53 Patient positioned. Setup error 0.4 mm.
06:54-06:59 RT delivery in progress (continues into hour 07).
```

## Departures
None.

## Adverse Events
None.

## IND Administrations
- PAT-CONT-0013A: STREAM C2D1 ARM-B (placebo), 60 mg saline equivalent over
  60 min, completed 06:30. Drug accountability log entry IDA-0089-001.

## Cross-Site Utilization
- SITE-A: 51 robot-min (SURG-01 + RTPOS-01 + TRACK-01 setup)
- SITE-B: 25 robot-min (NEEDLE-01)
- SITE-C: 30 robot-min (HUMAN-01 IND completion)
- SITE-D: 16 robot-min (COMPN-05)
- Network utilization: 1.76%

## RTCT Signal Stream

| Signal ID | Patient | Endpoint | FDA Ack |
|-----------|---------|----------|---------|
| STREAM-CONT-0013A-IND-C2D1 | PAT-CONT-0013A | C2D1 dose complete | 9 s |
| TRAVERSE-CONT-0014A-SURG01 | PAT-CONT-0014A | Mass excised | 10 s |
| TRAVERSE-CONT-0015A-BX01 | PAT-CONT-0015A | Tissue acquired | 12 s |
| TRAVERSE-PED-CONT-0016A-MAINT01 | PAT-CONT-0016A | Maintenance dose | 11 s |
